Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117347) titled 'the Safety and Efficacy of Percutaneous Ablation Combined with Systemic Therapy for Stable Stage of Non-Small Cell Lung Cancer patients with Oligometastases' on Jan. 22.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: People's Hospital of Leshan
Condition:
Advanced non-small cell lung cancer with oligometastasis in a stable phase
Intervention:
Local ablation combined with systemic therapy group:Localized ablation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-31
Target Sample Size: Local ablation combined with systemic therapy...